Finance

Lists
Why is C68 up 5,83%?
Dive Deeper
C68:FRA
Crescent Biopharma Inc
€10,90
+5,83%
(+0,60) 1D
21 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
€10,90
High
€10,90
Low
€10,90
Mkt. cap
489,19 m
Avg. vol.
13,00
Volume
0,00
52-wk high
€22,80
52-wk low
€6,70
No. of employees
69
Open
€10,90
High
€10,90
Low
€10,90
Mkt. cap
489,19 m
Avg. vol.
13,00
Volume
0,00
52-wk high
€22,80
52-wk low
€6,70
No. of employees
69
News stories
From web sources and news partners
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersWaltham, Massachusetts, Verenigde State van Amerika
Sector-
Websitecrescentbiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
10,84 m
1,04 m
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20,35 m
95,03 m
17,90 m
19,39 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,54 m
7,31 m
7,86 m
8,74 m
Operating expense
25,88 m
102,34 m
25,77 m
28,13 m
Total operating expenses
25,88 m
102,34 m
25,77 m
28,13 m
Operating income
-25,88 m
-91,49 m
-24,73 m
-28,13 m
Other non operating income
-
-
-
-
EBT including unusual items
-24,61 m
-90,40 m
-23,28 m
-24,84 m
EBT excluding unusual items
-24,61 m
-90,40 m
-23,28 m
-26,61 m
Income tax expense
-
2,00 m
-
-
Effective tax rate
-
-2,21%
-
-
Other operating expenses
-
-
-
-
Net income
-24,61 m
-92,40 m
-23,28 m
-24,84 m
Net profit margin
-
-852,06%
-2 240,90%
-
Earnings per share
-1,37
-4,92
-0,70
-0,62
Interest and investment income
1,28 m
1,10 m
1,45 m
1,53 m
Interest expense
-
-
-
-
Net interest expenses
1,28 m
1,10 m
1,45 m
1,53 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-25,86 m
-91,44 m
-24,66 m
-28,07 m
Gain or loss from assets sale
-
-
-
-1,77 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme